அருண் சாண்டவர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அருண் சாண்டவர்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அருண் சாண்டவர்கள் Today - Breaking & Trending Today

Industry-Academia-Government Collaboration is the Need of the Hour: Experts at PanIIT India Event

Industry-Academia-Government Collaboration is the Need of the Hour: Experts at PanIIT India Event
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

Jammu And Kashmir , United States , New Delhi , Tamil Nadu , Sanjay Kaul , Desh Deshpande , Tami Nadu , K Ananth Krishnan , Irina Ghose , Kris Gopalakrishnan , Sumit Gupta , Krishenk Dhar , Jeyandran Venugopal , Abhinav Sinha , Arun Chandavarkar , Ashutosh Sharma , Shri Mk Stalin , Manoj Sinha , Asha Jadeja Motwani , Asmita Ojha , Shri Manoj Sinha , Biocon Biologics Ltd , Cloud Solutions , Service Provider Business , Motwani Jadeja Family Foundation , Global Virtual Technology Summit On ,

Industry-Academia-Government collaboration is need of hour

Industry-Academia-Government collaboration is need of hour
greekherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from greekherald.com Daily Mail and Mail on Sunday newspapers.

United States , Tamil Nadu , Jeyandran Venugopal , Sanjay Kaul , Desh Deshpande , Arun Chandavarkar , Abhinav Sinha , Tami Nadu , Ashutosh Sharma , K Ananth Krishnan , Irina Ghose , Kris Gopalakrishnan , Asmita Ojha , Sumit Gupta , Manoj Sinha , Asha Jadeja Motwani , Krishenk Dhar , Biocon Biologics Ltd , Cloud Solutions , Service Provider Business , Motwani Jadeja Family Foundation , Global Virtual Technology Summit On , Department Of Science , New Delhi , Virtual Technology Summit , Chief Minister ,

Industry-Academia-Government Collaboration is the Need of the Hour: Experts at PanIIT India Event

Industry-Academia-Government Collaboration is the Need of the Hour: Experts at PanIIT India Event
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

Jammu And Kashmir , United States , New Delhi , Tamil Nadu , Sanjay Kaul , Desh Deshpande , Tami Nadu , K Ananth Krishnan , Irina Ghose , Kris Gopalakrishnan , Sumit Gupta , Krishenk Dhar , Jeyandran Venugopal , Abhinav Sinha , Arun Chandavarkar , Ashutosh Sharma , Shri Mk Stalin , Asha Jadeja Motwani , Asmita Ojha , Shri Manoj Sinha , Biocon Biologics Ltd , Cloud Solutions , Service Provider Business , Motwani Jadeja Family Foundation , Global Virtual Technology Summit On , Department Of Science ,

Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes

Share this article
Share this article
PITTSBURGH and BENGALURU, India, July 28, 2021 /PRNewswire/ Viatris Inc. (NASDAQ: VTRS) and Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) today announced that the U.S. Food and Drug Administration (FDA) has approved Semglee
® (insulin glargine-yfgn) injection as the first interchangeable biosimilar product under the 351(k) regulatory pathway.
Biocon Biologics
Viatris CEO Michael Goettler commented: We are extremely proud to achieve the industry s first approval of an interchangeable biosimilar product in the U.S., which will help broaden access to this important diabetes medicine for patients, physicians, payers and providers. This is yet another important milestone for our company that not only continues to underscore the strength of our internal scientific capabilities, but also supports our belief in the promising future of our company as we continue to work to identify innovative ways to increase access to co ....

United States , Andhra Pradesh , New Zealand , Kiran Mazumdar Shaw , Rajiv Malik , Arun Chandavarkar , Biocon Biologics , Viatris Biocon Biologics , European Free Trade Association , Exchange Commission , Pfizer Inc , European Union , Viatris Inc , Viatris President Rajiv Malik , Executive Chairperson , Biosimilar Insulin Glargine , Biologics Managing Director Arun Chandavarkar , Biocon Biologic , Global Healthcare , Biologics Limited , Biocon Limited , Generic Formulations , Looking Statements , Private Securities Litigation Reform Act , Fair Disclosure , Neither Biocon ,

Biocon's Semglee gets USFDA approval; first interchangeable biosimilar product in US

Biocon s Semglee gets USFDA approval; first interchangeable biosimilar product in US
SECTIONS
Last Updated: Jul 29, 2021, 09:56 AM IST
Share
Synopsis
“It is a milestone achievement for both Biocon Biologics and our partner Viatris. This will allow pharmacy level substitution and thereby provide convenient and affordable access to Semglee, a quality Biosimilar Insulin Glargine,” Biocon Biologics, Executive Chairperson, Kiran Mazumdar-Shaw said in a statement.
The company is eligible to have exclusivity for 12 months before the FDA can approve another biosimilar interchangeable to Lantus.
Biocon Biologics Ltd, a unit of Biocon and Viatris Inc said on Thursday that the U.S. Food and Drug Administration (FDA) has approved its insulin glargine-yfgn injection branded Semglee in the US market. ....

Kiran Mazumdar Shaw , Arun Chandavarkar , Biocon Biologics , Viatris Biocon Biologics , Biologics Ltd , Drug Administration , Viatris Inc , Biosimilar Insulin Glargine , Executive Chairperson , Biologics Managing Director Arun Chandavarkar , Biocon Biologic , கிறன் மஜும்தர் ஷா , அருண் சாண்டவர்கள் , பயோகான் உயிரியல் , உயிரியல் லிமிடெட் , நிர்வாகி தலைவர் ,